ClinicalTrials.gov
public full text
Public Domain
Atrial Fibrillation Incidence, Risk Factors and Genetics
arrhythmiaatrial-fibrillationcardiovascular-diseasescerebrovascular-accidentheart-diseaseshypertension
To assess the risk of incident atrial fibrillation after stopping anti-hypertensive medication including beta-blockers and ACE inhibitors. Also, to assess the role of genetics in subsequent risk of stroke among patients with atrial fibrillation.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- THE GIRAFFE Study: Genomic Risk Markers for Atrial Fibrillation Following Extended Cardiac Rhythm Monitoring#1228623
- Cardiovascular Registry of Atrial Fibrillation#1163303
- The Influence of Genetic Predisposition on Outcome After Catheter Ablation of Atrial Fibrillation.#1057517
- Freely available genomic datasets for atrial fibrillation research: current resources and analytical pipeline.#666087
- Defining the Risk of Ventricular Tachycardia in Genetic Forms of Early-onset Atrial Fibrillation#1308625
Record · ID 1365189
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive